_id
69130308ccc777a4e85d79dc
Ticker
IPSEY
Name
Ipsen SA ADR
Exchange
PINK
Address
70 rue Balard, Paris, France, 75015
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.ipsen.com
Description
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer; Tazverik, a chemotherapy-free EZH2a inhibitor that is in phase III clinical trial for the treatment of second line follicular lymphoma; Tovorafenib that is in phase III clinical trial to treat first line pediatric Low-Grade Gliomas and is In phase II clinical trial for the treatment of relapsed/refractory pediatric Low-Grade Gliomas; and IPN01194 and IPN01195 that is in phase I to treat solid tumors. The company is also developing products for rare disease comprising Bylvay for the treatment of progressive familial intrahepatic cholestasis; Iqirvo, a peroxisome proliferator-activated receptor agonist to treat primary biliary cholangitis; NutropinAq, a liquid formulation of recombinant human growth hormone; Increlex, a recombinant human insulin-like growth factor; Fidrisertib that is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressive; Ritivixibat that is in phase II clinical trial to treat primary sclerosing cholangitis. In addition, it develops neuroscience products, such as Dysport that is in phase III clinical trial for the treatment of chronic and episodic migraine; and IPN10200 that is in phase II to treat aesthetic and therapeutic indications. The company has a partnership with Simcere Zaiming Pharmaceutical Co., Ltd. for the development of SIM0613, a protein expressed on varies tumor types and cancer-associated fibroblasts. The company was founded in 1929 and is headquartered in Paris, France.
Last Close
36.36
Volume
-
Current Price
36.8
Change
0
Last Updated
2026-01-04T15:21:58.877Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
11984560128
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7826777777777777
Sentiment Sources
9
Current Quarter
2025-06-30
Revenue
1937100000
Cost Of Revenue
325100000
Gross Profit
1612000000
Operating Expenses
1160400000
Operating Income
451600000
Interest Expense
4200000
Pretax Income
425000000
Net Income
334000000
Eps
1
Dividends Per Share
116200000
Shares Outstanding
329608348
Income Tax Expense
89500000
EBITDA
677600000
Operating Margin
23.31320014454597
Total Other Income Expense Net
-26600000
Cash
1445000000
Short Term Investments
1800000
Receivables
787300000
Inventories
253600000
Total Current Assets
2814100000
Property Plant Equipment
665300000
Total Assets
6830500000
Payables
852000000
Short Term Debt
33600000
Long Term Debt
745600000
Total Liabilities
2600100000
Equity
4229100000
Bs_currency_symbol
EUR
Depreciation
191400000
Change In Working Capital
-75800000
Cash From Operations
526700000
Capital Expenditures
55200000
Cash From Investing
-132900000
Cash From Financing
354700000
Net Change In Cash
1442900000
Cf_currency_symbol
-
PE
23.0127
PB
2.9063394102764177
ROE
7.897661440968527
ROA
4.889832369519069
FCF
471500000
Fcf Percent
0.24340509008311392
Piotroski FScore
4
Health Score
76
Deep Value Investing Score
5.5
Defensive Investing Score
6.5
Dividend Investing Score
3.5
Economic Moat Investing Score
7.5
Garp Investing Score
6.5
Growth Investing Score
5.5
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
7.5
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1937100000
Quarters > 0 > income Statement > cost Of Revenue
325100000
Quarters > 0 > income Statement > gross Profit
1612000000
Quarters > 0 > income Statement > operating Expenses
1160400000
Quarters > 0 > income Statement > operating Income
451600000
Quarters > 0 > income Statement > interest Expense
4200000
Quarters > 0 > income Statement > pretax Income
425000000
Quarters > 0 > income Statement > net Income
334000000
Quarters > 0 > income Statement > eps
1
Quarters > 0 > income Statement > dividends Per Share
116200000
Quarters > 0 > income Statement > shares Outstanding
334000000
Quarters > 0 > income Statement > income Tax Expense
89500000
Quarters > 0 > income Statement > EBITDA
677600000
Quarters > 0 > income Statement > operating Margin
23.31320014454597
Quarters > 0 > income Statement > total Other Income Expense Net
-26600000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1445000000
Quarters > 0 > balance Sheet > short Term Investments
1800000
Quarters > 0 > balance Sheet > receivables
787300000
Quarters > 0 > balance Sheet > inventories
253600000
Quarters > 0 > balance Sheet > total Current Assets
2814100000
Quarters > 0 > balance Sheet > property Plant Equipment
665300000
Quarters > 0 > balance Sheet > total Assets
6830500000
Quarters > 0 > balance Sheet > payables
852000000
Quarters > 0 > balance Sheet > short Term Debt
33600000
Quarters > 0 > balance Sheet > long Term Debt
745600000
Quarters > 0 > balance Sheet > total Liabilities
2600100000
Quarters > 0 > balance Sheet > equity
4229100000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
334000000
Quarters > 0 > cash Flow > depreciation
191400000
Quarters > 0 > cash Flow > change In Working Capital
-75800000
Quarters > 0 > cash Flow > cash From Operations
526700000
Quarters > 0 > cash Flow > capital Expenditures
55200000
Quarters > 0 > cash Flow > cash From Investing
-132900000
Quarters > 0 > cash Flow > cash From Financing
354700000
Quarters > 0 > cash Flow > net Change In Cash
1442900000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1
Quarters > 0 > ratios > PB
2.9063394102764177
Quarters > 0 > ratios > ROE
7.897661440968527
Quarters > 0 > ratios > ROA
4.889832369519069
Quarters > 0 > ratios > FCF
471500000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.24340509008311392
Quarters > 0 > health Score
76
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1822700000
Quarters > 1 > income Statement > cost Of Revenue
302000000
Quarters > 1 > income Statement > gross Profit
1520700000
Quarters > 1 > income Statement > operating Expenses
1341800000
Quarters > 1 > income Statement > operating Income
178900000
Quarters > 1 > income Statement > interest Expense
12900000
Quarters > 1 > income Statement > pretax Income
142700000
Quarters > 1 > income Statement > net Income
113900000
Quarters > 1 > income Statement > eps
0.3419737787356753
Quarters > 1 > income Statement > dividends Per Share
200000
Quarters > 1 > income Statement > shares Outstanding
333066472
Quarters > 1 > income Statement > income Tax Expense
27700000
Quarters > 1 > income Statement > EBITDA
679600000
Quarters > 1 > income Statement > operating Margin
9.81510945300927
Quarters > 1 > income Statement > total Other Income Expense Net
-36200000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
678100000
Quarters > 1 > balance Sheet > short Term Investments
1100000
Quarters > 1 > balance Sheet > receivables
697200000
Quarters > 1 > balance Sheet > inventories
285500000
Quarters > 1 > balance Sheet > total Current Assets
2021200000
Quarters > 1 > balance Sheet > property Plant Equipment
664200000
Quarters > 1 > balance Sheet > total Assets
6439000000
Quarters > 1 > balance Sheet > payables
854800000
Quarters > 1 > balance Sheet > short Term Debt
37200000
Quarters > 1 > balance Sheet > long Term Debt
287500000
Quarters > 1 > balance Sheet > total Liabilities
2257200000
Quarters > 1 > balance Sheet > equity
4181600000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
125300000
Quarters > 1 > cash Flow > depreciation
520900000
Quarters > 1 > cash Flow > change In Working Capital
79600000
Quarters > 1 > cash Flow > cash From Operations
449500000
Quarters > 1 > cash Flow > capital Expenditures
723200000
Quarters > 1 > cash Flow > cash From Investing
-477500000
Quarters > 1 > cash Flow > cash From Financing
218200000
Quarters > 1 > cash Flow > net Change In Cash
210100000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.3419737787356753
Quarters > 1 > ratios > PB
2.9311378825330014
Quarters > 1 > ratios > ROE
2.723837765448632
Quarters > 1 > ratios > ROA
1.7689082155614224
Quarters > 1 > ratios > FCF
-273700000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
-0.15016184780819664
Quarters > 1 > health Score
51
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1751800000
Quarters > 2 > income Statement > cost Of Revenue
316700000
Quarters > 2 > income Statement > gross Profit
1435100000
Quarters > 2 > income Statement > operating Expenses
1117300000
Quarters > 2 > income Statement > operating Income
317800000
Quarters > 2 > income Statement > interest Expense
10900000
Quarters > 2 > income Statement > pretax Income
289500000
Quarters > 2 > income Statement > net Income
232000000
Quarters > 2 > income Statement > eps
0.6950000034150863
Quarters > 2 > income Statement > dividends Per Share
99800000
Quarters > 2 > income Statement > shares Outstanding
333812948
Quarters > 2 > income Statement > income Tax Expense
47200000
Quarters > 2 > income Statement > EBITDA
481700000
Quarters > 2 > income Statement > operating Margin
18.141340335654753
Quarters > 2 > income Statement > total Other Income Expense Net
-28300000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
485400000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
719200000
Quarters > 2 > balance Sheet > inventories
272700000
Quarters > 2 > balance Sheet > total Current Assets
1899800000
Quarters > 2 > balance Sheet > property Plant Equipment
594200000
Quarters > 2 > balance Sheet > total Assets
6547200000
Quarters > 2 > balance Sheet > payables
857600000
Quarters > 2 > balance Sheet > short Term Debt
135100000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2501100000
Quarters > 2 > balance Sheet > equity
4046900000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
232000000
Quarters > 2 > cash Flow > depreciation
185000000
Quarters > 2 > cash Flow > change In Working Capital
-134100000
Quarters > 2 > cash Flow > cash From Operations
466000000
Quarters > 2 > cash Flow > capital Expenditures
59300000
Quarters > 2 > cash Flow > cash From Investing
-199100000
Quarters > 2 > cash Flow > cash From Financing
-111100000
Quarters > 2 > cash Flow > net Change In Cash
467500000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.6950000034150863
Quarters > 2 > ratios > PB
3.0354880245125897
Quarters > 2 > ratios > ROE
5.7327831179421285
Quarters > 2 > ratios > ROA
3.543499511241447
Quarters > 2 > ratios > FCF
406700000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.23216120561707956
Quarters > 2 > health Score
68
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
330818424
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-
Quarters > 3 > cash Flow > depreciation
43276
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
-
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3574500000
Annuals > 0 > income Statement > cost Of Revenue
618700000
Annuals > 0 > income Statement > gross Profit
2955800000
Annuals > 0 > income Statement > operating Expenses
2459100000
Annuals > 0 > income Statement > operating Income
496700000
Annuals > 0 > income Statement > interest Expense
23800000
Annuals > 0 > income Statement > pretax Income
432200000
Annuals > 0 > income Statement > net Income
345900000
Annuals > 0 > income Statement > eps
1.0369737782278412
Annuals > 0 > income Statement > dividends Per Share
99600000
Annuals > 0 > income Statement > shares Outstanding
333566776
Annuals > 0 > income Statement > income Tax Expense
74900000
Annuals > 0 > income Statement > EBITDA
1161300000
Annuals > 0 > income Statement > operating Margin
13.895649741222549
Annuals > 0 > income Statement > total Other Income Expense Net
-64500000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
678100000
Annuals > 0 > balance Sheet > short Term Investments
1100000
Annuals > 0 > balance Sheet > receivables
697200000
Annuals > 0 > balance Sheet > inventories
285500000
Annuals > 0 > balance Sheet > total Current Assets
2021200000
Annuals > 0 > balance Sheet > property Plant Equipment
664200000
Annuals > 0 > balance Sheet > total Assets
6439000000
Annuals > 0 > balance Sheet > payables
854800000
Annuals > 0 > balance Sheet > short Term Debt
37200000
Annuals > 0 > balance Sheet > long Term Debt
287500000
Annuals > 0 > balance Sheet > total Liabilities
2257200000
Annuals > 0 > balance Sheet > equity
4181600000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
357300000
Annuals > 0 > cash Flow > depreciation
705900000
Annuals > 0 > cash Flow > change In Working Capital
-54500000
Annuals > 0 > cash Flow > cash From Operations
915500000
Annuals > 0 > cash Flow > capital Expenditures
782500000
Annuals > 0 > cash Flow > cash From Investing
-676600000
Annuals > 0 > cash Flow > cash From Financing
-100000000
Annuals > 0 > cash Flow > net Change In Cash
158100000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
1.0369737782278412
Annuals > 0 > ratios > PB
2.9004419302085327
Annuals > 0 > ratios > ROE
8.271953319303616
Annuals > 0 > ratios > ROA
5.371952166485479
Annuals > 0 > ratios > FCF
133000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.037208001119037624
Annuals > 0 > health Score
61
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
3306400000
Annuals > 1 > income Statement > cost Of Revenue
571200000
Annuals > 1 > income Statement > gross Profit
2735200000
Annuals > 1 > income Statement > operating Expenses
1919200000
Annuals > 1 > income Statement > operating Income
816000000
Annuals > 1 > income Statement > interest Expense
37700000
Annuals > 1 > income Statement > pretax Income
756100000
Annuals > 1 > income Statement > net Income
644400000
Annuals > 1 > income Statement > eps
1.9322289699245383
Annuals > 1 > income Statement > dividends Per Share
99600000
Annuals > 1 > income Statement > shares Outstanding
333500848
Annuals > 1 > income Statement > income Tax Expense
136200000
Annuals > 1 > income Statement > EBITDA
887100000
Annuals > 1 > income Statement > operating Margin
24.679409629808855
Annuals > 1 > income Statement > total Other Income Expense Net
-59900000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
528400000
Annuals > 1 > balance Sheet > short Term Investments
10600000
Annuals > 1 > balance Sheet > receivables
631300000
Annuals > 1 > balance Sheet > inventories
289500000
Annuals > 1 > balance Sheet > total Current Assets
1898400000
Annuals > 1 > balance Sheet > property Plant Equipment
574600000
Annuals > 1 > balance Sheet > total Assets
6322900000
Annuals > 1 > balance Sheet > payables
771400000
Annuals > 1 > balance Sheet > short Term Debt
36400000
Annuals > 1 > balance Sheet > long Term Debt
269700000
Annuals > 1 > balance Sheet > total Liabilities
2499100000
Annuals > 1 > balance Sheet > equity
3825100000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
617100000
Annuals > 1 > cash Flow > depreciation
87900000
Annuals > 1 > cash Flow > change In Working Capital
76100000
Annuals > 1 > cash Flow > cash From Operations
865900000
Annuals > 1 > cash Flow > capital Expenditures
182900000
Annuals > 1 > cash Flow > cash From Investing
-1078200000
Annuals > 1 > cash Flow > cash From Financing
-435800000
Annuals > 1 > cash Flow > net Change In Cash
-646000000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
1.9322289699245383
Annuals > 1 > ratios > PB
3.1701369462968287
Annuals > 1 > ratios > ROE
16.846618389061724
Annuals > 1 > ratios > ROA
10.191526040266334
Annuals > 1 > ratios > FCF
683000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.20656907815146383
Annuals > 1 > health Score
83
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3156500000
Annuals > 2 > income Statement > cost Of Revenue
527700000
Annuals > 2 > income Statement > gross Profit
2628800000
Annuals > 2 > income Statement > operating Expenses
1898900000
Annuals > 2 > income Statement > operating Income
729900000
Annuals > 2 > income Statement > interest Expense
18500000
Annuals > 2 > income Statement > pretax Income
704400000
Annuals > 2 > income Statement > net Income
648600000
Annuals > 2 > income Statement > eps
1.9513141405772918
Annuals > 2 > income Statement > dividends Per Share
99300000
Annuals > 2 > income Statement > shares Outstanding
332391380
Annuals > 2 > income Statement > income Tax Expense
112300000
Annuals > 2 > income Statement > EBITDA
1130900000
Annuals > 2 > income Statement > operating Margin
23.123712973229843
Annuals > 2 > income Statement > total Other Income Expense Net
-25500000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
1169300000
Annuals > 2 > balance Sheet > short Term Investments
31000000
Annuals > 2 > balance Sheet > receivables
632500000
Annuals > 2 > balance Sheet > inventories
284100000
Annuals > 2 > balance Sheet > total Current Assets
2397600000
Annuals > 2 > balance Sheet > property Plant Equipment
581400000
Annuals > 2 > balance Sheet > total Assets
5607900000
Annuals > 2 > balance Sheet > payables
647100000
Annuals > 2 > balance Sheet > short Term Debt
104600000
Annuals > 2 > balance Sheet > long Term Debt
581800000
Annuals > 2 > balance Sheet > total Liabilities
2271200000
Annuals > 2 > balance Sheet > equity
3337300000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
592100000
Annuals > 2 > cash Flow > depreciation
336500000
Annuals > 2 > cash Flow > change In Working Capital
-39100000
Annuals > 2 > cash Flow > cash From Operations
971400000
Annuals > 2 > cash Flow > capital Expenditures
252900000
Annuals > 2 > cash Flow > cash From Investing
-458600000
Annuals > 2 > cash Flow > cash From Financing
-164200000
Annuals > 2 > cash Flow > net Change In Cash
356400000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
1.9513141405772918
Annuals > 2 > ratios > PB
3.621415688370839
Annuals > 2 > ratios > ROE
19.43487250172295
Annuals > 2 > ratios > ROA
11.565826780078105
Annuals > 2 > ratios > FCF
718500000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.22762553461111992
Annuals > 2 > health Score
85
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2748700000
Annuals > 3 > income Statement > cost Of Revenue
538000000
Annuals > 3 > income Statement > gross Profit
2310100000
Annuals > 3 > income Statement > operating Expenses
1485400000
Annuals > 3 > income Statement > operating Income
824700000
Annuals > 3 > income Statement > interest Expense
23700000
Annuals > 3 > income Statement > pretax Income
789200000
Annuals > 3 > income Statement > net Income
646600000
Annuals > 3 > income Statement > eps
1.9392160787680899
Annuals > 3 > income Statement > dividends Per Share
82900000
Annuals > 3 > income Statement > shares Outstanding
333433704
Annuals > 3 > income Statement > income Tax Expense
158300000
Annuals > 3 > income Statement > EBITDA
1059300000
Annuals > 3 > income Statement > operating Margin
30.00327427511187
Annuals > 3 > income Statement > total Other Income Expense Net
-35500000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
814700000
Annuals > 3 > balance Sheet > short Term Investments
42400000
Annuals > 3 > balance Sheet > receivables
564300000
Annuals > 3 > balance Sheet > inventories
219400000
Annuals > 3 > balance Sheet > total Current Assets
1953800000
Annuals > 3 > balance Sheet > property Plant Equipment
647500000
Annuals > 3 > balance Sheet > total Assets
5006800000
Annuals > 3 > balance Sheet > payables
594700000
Annuals > 3 > balance Sheet > short Term Debt
35300000
Annuals > 3 > balance Sheet > long Term Debt
562800000
Annuals > 3 > balance Sheet > total Liabilities
2252800000
Annuals > 3 > balance Sheet > equity
2735200000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
646700000
Annuals > 3 > cash Flow > depreciation
237000000
Annuals > 3 > cash Flow > change In Working Capital
-32200000
Annuals > 3 > cash Flow > cash From Operations
909200000
Annuals > 3 > cash Flow > capital Expenditures
427700000
Annuals > 3 > cash Flow > cash From Investing
-344200000
Annuals > 3 > cash Flow > cash From Financing
-401200000
Annuals > 3 > cash Flow > net Change In Cash
169500000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
1.9392160787680899
Annuals > 3 > ratios > PB
4.432454474056741
Annuals > 3 > ratios > ROE
23.639953202690844
Annuals > 3 > ratios > ROA
12.914436366541505
Annuals > 3 > ratios > FCF
481500000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.17517371848510205
Annuals > 3 > health Score
83
Valuation > metrics > PE
23.0127
Valuation > metrics > PB
2.9063394102764177
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
7.897661440968527
Profitability > metrics > ROA
11.868803525105717
Profitability > metrics > Net Margin
0.17242269371741262
Profitability > final Score
72
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.6148116620557565
Risk > metrics > Interest Coverage
107.52380952380952
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
3.1776196928635954
Liquidity > metrics > Quick Ratio
2.891260162601626
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
69.6451197548741
Prev Valuations > 2
50
Prev Profitabilities > 0
32
Prev Profitabilities > 1
61
Prev Profitabilities > 2
50
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
98
Prev Liquidities > 2
50
Updated At
2026-01-20T22:02:42.148Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-11
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-22
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-31
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
4
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-16
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
1.37
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
1.37
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-21
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
1.37
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
1.37
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-23
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-07-25
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-04-24
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-12
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
1.43
Earnings History > 8 > eps Difference
-1.43
Earnings History > 8 > surprise Percent
-100
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-10-26
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-07-27
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
1.37
Earnings History > 10 > eps Estimate
1.37
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-04-27
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-10-27
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-07-28
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-27
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-11
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-10-21
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-29
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-04-22
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
2.1499
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
2.1499
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-11
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
7.31
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
7.31
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-10-22
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
2.3677
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
2.3677
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
3.55
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
3.55
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-04-22
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
1.4851
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
1.4851
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-13
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
6.74
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
6.74
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-10-24
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
-1.8276
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-1.8276
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-07-25
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
-1.776
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-1.776
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-04-24
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
1.4731
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
1.4731
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-14
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
5.91
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
5.91
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-10-25
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
1.3011
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
1.3011
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-07-26
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
0.8337
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
0.8337
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-04-26
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
EUR
Earnings History > 31 > eps Actual
1.3888
Earnings History > 31 > eps Estimate
0.85
Earnings History > 31 > eps Difference
0.5388
Earnings History > 31 > surprise Percent
63.3882
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-02-15
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
EUR
Earnings History > 32 > eps Actual
1.4651
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
1.4651
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-10-26
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
EUR
Earnings History > 33 > eps Actual
1.049
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
1.049
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-07-27
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
EUR
Earnings History > 34 > eps Actual
1.0334
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
1.0334
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-04-27
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
EUR
Earnings History > 35 > eps Actual
0.857
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
0.857
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-02-23
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
EUR
Earnings History > 36 > eps Actual
3.18
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
3.18
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-10-26
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
EUR
Earnings History > 37 > eps Actual
0.5875
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
0.5875
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-09-30
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
EUR
Earnings History > 38 > eps Actual
0.627
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
0.627
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-06-30
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
EUR
Earnings History > 39 > eps Actual
0.896
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
0.896
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2015-12-31
Earnings History > 40 > report Date
2016-03-31
Earnings History > 40 > date
2015-12-31
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
EUR
Earnings History > 40 > eps Actual
0.9189
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
0.9189
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-09-30
Earnings History > 41 > report Date
2015-12-31
Earnings History > 41 > date
2015-09-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
EUR
Earnings History > 41 > eps Actual
0.6536
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
0.6536
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2015-06-30
Earnings History > 42 > report Date
2015-09-30
Earnings History > 42 > date
2015-06-30
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
EUR
Earnings History > 42 > eps Actual
0.6716
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
0.6716
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2015-03-31
Earnings History > 43 > report Date
2015-06-30
Earnings History > 43 > date
2015-03-31
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
EUR
Earnings History > 43 > eps Actual
0.6051
Earnings History > 43 > eps Estimate
0
Earnings History > 43 > eps Difference
0.6051
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2014-12-31
Earnings History > 44 > report Date
2015-03-31
Earnings History > 44 > date
2014-12-31
Earnings History > 44 > before After Market
-
Earnings History > 44 > currency
EUR
Earnings History > 44 > eps Actual
0.5835
Earnings History > 44 > eps Estimate
0
Earnings History > 44 > eps Difference
0.5835
Earnings History > 44 > surprise Percent
-
Earnings History > 45 > period
2014-09-30
Earnings History > 45 > report Date
2014-12-31
Earnings History > 45 > date
2014-09-30
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
EUR
Earnings History > 45 > eps Actual
0.3644
Earnings History > 45 > eps Estimate
0
Earnings History > 45 > eps Difference
0.3644
Earnings History > 45 > surprise Percent
-
Earnings History > 46 > period
2014-06-30
Earnings History > 46 > report Date
2014-09-30
Earnings History > 46 > date
2014-06-30
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
EUR
Earnings History > 46 > eps Actual
0.38
Earnings History > 46 > eps Estimate
0
Earnings History > 46 > eps Difference
0.38
Earnings History > 46 > surprise Percent
-
Earnings History > 47 > period
2014-03-31
Earnings History > 47 > report Date
2014-06-30
Earnings History > 47 > date
2014-03-31
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
EUR
Earnings History > 47 > eps Actual
0.8664
Earnings History > 47 > eps Estimate
0
Earnings History > 47 > eps Difference
0.8664
Earnings History > 47 > surprise Percent
-
Earnings History > 48 > period
2013-12-31
Earnings History > 48 > report Date
2014-03-31
Earnings History > 48 > date
2013-12-31
Earnings History > 48 > before After Market
-
Earnings History > 48 > currency
EUR
Earnings History > 48 > eps Actual
0.8697
Earnings History > 48 > eps Estimate
0
Earnings History > 48 > eps Difference
0.8697
Earnings History > 48 > surprise Percent
-
Earnings History > 49 > period
2013-09-30
Earnings History > 49 > report Date
2013-12-31
Earnings History > 49 > date
2013-09-30
Earnings History > 49 > before After Market
-
Earnings History > 49 > currency
EUR
Earnings History > 49 > eps Actual
0.4252
Earnings History > 49 > eps Estimate
0
Earnings History > 49 > eps Difference
0.4252
Earnings History > 49 > surprise Percent
-
Earnings History > 50 > period
2013-06-30
Earnings History > 50 > report Date
2013-09-30
Earnings History > 50 > date
2013-06-30
Earnings History > 50 > before After Market
-
Earnings History > 50 > currency
EUR
Earnings History > 50 > eps Actual
0.4179
Earnings History > 50 > eps Estimate
0
Earnings History > 50 > eps Difference
0.4179
Earnings History > 50 > surprise Percent
-
Earnings History > 51 > period
2013-03-31
Earnings History > 51 > report Date
2013-06-30
Earnings History > 51 > date
2013-03-31
Earnings History > 51 > before After Market
-
Earnings History > 51 > currency
EUR
Earnings History > 51 > eps Actual
0.6993
Earnings History > 51 > eps Estimate
0
Earnings History > 51 > eps Difference
0.6993
Earnings History > 51 > surprise Percent
-
Earnings History > 52 > period
2012-12-31
Earnings History > 52 > report Date
2013-03-31
Earnings History > 52 > date
2012-12-31
Earnings History > 52 > before After Market
-
Earnings History > 52 > currency
EUR
Earnings History > 52 > eps Actual
0.6906
Earnings History > 52 > eps Estimate
0
Earnings History > 52 > eps Difference
0.6906
Earnings History > 52 > surprise Percent
-
Earnings History > 53 > period
2012-03-31
Earnings History > 53 > report Date
2012-06-30
Earnings History > 53 > date
2012-03-31
Earnings History > 53 > before After Market
-
Earnings History > 53 > currency
EUR
Earnings History > 53 > eps Actual
0.7489
Earnings History > 53 > eps Estimate
0
Earnings History > 53 > eps Difference
0.7489
Earnings History > 53 > surprise Percent
-
Earnings History > 54 > period
2011-12-31
Earnings History > 54 > report Date
2012-03-31
Earnings History > 54 > date
2011-12-31
Earnings History > 54 > before After Market
-
Earnings History > 54 > currency
EUR
Earnings History > 54 > eps Actual
0.8005
Earnings History > 54 > eps Estimate
0
Earnings History > 54 > eps Difference
0.8005
Earnings History > 54 > surprise Percent
-
Earnings History > 55 > period
2011-09-30
Earnings History > 55 > report Date
2011-12-31
Earnings History > 55 > date
2011-09-30
Earnings History > 55 > before After Market
-
Earnings History > 55 > currency
EUR
Earnings History > 55 > eps Actual
-0.1484
Earnings History > 55 > eps Estimate
0
Earnings History > 55 > eps Difference
-0.1484
Earnings History > 55 > surprise Percent
-
Earnings History > 56 > period
2011-06-30
Earnings History > 56 > report Date
2011-09-30
Earnings History > 56 > date
2011-06-30
Earnings History > 56 > before After Market
-
Earnings History > 56 > currency
EUR
Earnings History > 56 > eps Actual
-0.1536
Earnings History > 56 > eps Estimate
0
Earnings History > 56 > eps Difference
-0.1536
Earnings History > 56 > surprise Percent
-
Earnings History > 57 > period
2011-03-31
Earnings History > 57 > report Date
2011-06-30
Earnings History > 57 > date
2011-03-31
Earnings History > 57 > before After Market
-
Earnings History > 57 > currency
EUR
Earnings History > 57 > eps Actual
0.7894
Earnings History > 57 > eps Estimate
0
Earnings History > 57 > eps Difference
0.7894
Earnings History > 57 > surprise Percent
-
Earnings History > 58 > period
2010-12-31
Earnings History > 58 > report Date
2011-03-31
Earnings History > 58 > date
2010-12-31
Earnings History > 58 > before After Market
-
Earnings History > 58 > currency
EUR
Earnings History > 58 > eps Actual
0.7666
Earnings History > 58 > eps Estimate
0
Earnings History > 58 > eps Difference
0.7666
Earnings History > 58 > surprise Percent
-
Earnings History > 59 > period
2010-09-30
Earnings History > 59 > report Date
2010-12-31
Earnings History > 59 > date
2010-09-30
Earnings History > 59 > before After Market
-
Earnings History > 59 > currency
EUR
Earnings History > 59 > eps Actual
0.1591
Earnings History > 59 > eps Estimate
0
Earnings History > 59 > eps Difference
0.1591
Earnings History > 59 > surprise Percent
-
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer; Tazverik, a chemotherapy-free EZH2a inhibitor that is in phase III clinical trial for the treatment of second line follicular lymphoma; Tovorafenib that is in phase III clinical trial to treat first line pediatric Low-Grade Gliomas and is In phase II clinical trial for the treatment of relapsed/refractory pediatric Low-Grade Gliomas; and IPN01194 and IPN01195 that is in phase I to treat solid tumors. The company is also developing products for rare disease comprising Bylvay for the treatment of progressive familial intrahepatic cholestasis; Iqirvo, a peroxisome proliferator-activated receptor agonist to treat primary biliary cholangitis; NutropinAq, a liquid formulation of recombinant human growth hormone; Increlex, a recombinant human insulin-like growth factor; Fidrisertib that is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressive; Ritivixibat that is in phase II clinical trial to treat primary sclerosing cholangitis. In addition, it develops neuroscience products, such as Dysport that is in phase III clinical trial for the treatment of chronic and episodic migraine; and IPN10200 that is in phase II to treat aesthetic and therapeutic indications. The company has a partnership with Simcere Zaiming Pharmaceutical Co., Ltd. for the development of SIM0613, a protein expressed on varies tumor types and cancer-associated fibroblasts. The company was founded in 1929 and is headquartered in Paris, France.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIPSEN (OTCMKTS:IPSEY) Sees Unusually-High Trading Volume - Here's Why MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Ipsen SA ADR
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.